ALISON HAYES: Open Payments
NPI 1316592884 · HOMEWOOD, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,637 in 116 payments from 18 companies in 2025. Trend: 2023 $4,570 · 2024 $1,813 · 2025 $2,637
Food & beverage: $2,637
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 31 | $555 |
| Incyte Corporation | 19 | $510 |
| Novartis Pharmaceuticals Corporation | 15 | $272 |
| Lilly USA, LLC | 6 | $235 |
| MAYNE PHARMA COMMERCIAL LLC | 10 | $179 |
| GENZYME CORPORATION | 2 | $173 |
| Organon LLC | 8 | $145 |
| Gilead Sciences, Inc. | 1 | $118 |
| LEO Pharma Inc. | 3 | $61 |
| Regeneron Healthcare Solutions, Inc. | 2 | $55 |
Products named: OPZELURA, EBGLYSS, SKYRIZI, COSENTYX, RINVOQ, Biktarvy, BOTOX, VTAMA.
Industry payments across AL — which companies pay providers there.
